JP2008533079A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008533079A5 JP2008533079A5 JP2008501223A JP2008501223A JP2008533079A5 JP 2008533079 A5 JP2008533079 A5 JP 2008533079A5 JP 2008501223 A JP2008501223 A JP 2008501223A JP 2008501223 A JP2008501223 A JP 2008501223A JP 2008533079 A5 JP2008533079 A5 JP 2008533079A5
- Authority
- JP
- Japan
- Prior art keywords
- steroid sulfatase
- sulfatase inhibitor
- treatment
- pharmaceutical composition
- inflammatory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000009134 Steryl-Sulfatase Human genes 0.000 claims 4
- 108010087999 Steryl-Sulfatase Proteins 0.000 claims 4
- 239000003112 inhibitor Substances 0.000 claims 4
- 230000002401 inhibitory effect Effects 0.000 claims 4
- 200000000018 inflammatory disease Diseases 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agents Drugs 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000546 pharmaceutic aid Substances 0.000 claims 1
Claims (4)
- 炎症性疾患を処置するための薬剤の製造におけるステロイドスルファターゼ阻害剤の使用。
- 処置を必要とする対象に治療有効量のステロイドスルファターゼ阻害剤を投与することを含む炎症性疾患の処置法。
- 薬学的に許容される賦形剤に加えて、少なくとも１種のステロイドスルファターゼ阻害剤とさらなる抗炎症剤を共に含む医薬組成物。
- ステロイドスルファターゼ阻害剤が式
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0505541.3A GB0505541D0 (en) | 2005-03-17 | 2005-03-17 | Organic compounds |
| PCT/EP2006/002382 WO2006097292A1 (en) | 2005-03-17 | 2006-03-15 | Anti-inflammatory compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008533079A JP2008533079A (ja) | 2008-08-21 |
| JP2008533079A5 true JP2008533079A5 (ja) | 2009-04-16 |
Family
ID=34531452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008501223A Pending JP2008533079A (ja) | 2005-03-17 | 2006-03-15 | 抗炎症化合物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20090227620A1 (ja) |
| EP (1) | EP1861098A1 (ja) |
| JP (1) | JP2008533079A (ja) |
| KR (1) | KR20070113226A (ja) |
| CN (1) | CN101137375A (ja) |
| AU (1) | AU2006224796A1 (ja) |
| BR (1) | BRPI0607795A2 (ja) |
| CA (1) | CA2599470A1 (ja) |
| GB (1) | GB0505541D0 (ja) |
| MX (1) | MX2007011320A (ja) |
| RU (1) | RU2007138263A (ja) |
| WO (1) | WO2006097292A1 (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008092844A1 (en) * | 2007-01-31 | 2008-08-07 | Novartis Ag | Piperidin-acetamide derivatives for the treatment of inflammatory or allergic diseases |
| EP2207544A2 (en) | 2007-09-17 | 2010-07-21 | PregLem S.A. | Treatment of oestrogen dependant conditions in pre-menopausal women |
| TW200936136A (en) * | 2008-01-28 | 2009-09-01 | Sanofi Aventis | Tetrahydroquinoxaline urea derivatives, their preparation and their therapeutic application |
| CN103068813B (zh) | 2010-06-15 | 2016-02-24 | 拜耳知识产权有限责任公司 | 邻氨基苯甲酸二酰胺衍生物 |
| CN102657642B (zh) * | 2012-04-24 | 2014-01-15 | 广东省农业科学院兽医研究所 | Irosustat在制备抗柔嫩艾美耳球虫药物中的应用 |
| IN2014MN02574A (ja) | 2012-05-22 | 2015-07-24 | Genentech Inc | |
| CN107417601A (zh) * | 2017-04-06 | 2017-12-01 | 成都弥贝生物科技有限公司 | 具有抗菌活性的取代2‑酰胺磺酰基‑4,6‑芳基吡啶 |
| KR102458689B1 (ko) * | 2020-07-08 | 2022-10-25 | 원광대학교산학협력단 | 피페리딘 화합물 및 이의 제조 방법 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9807779D0 (en) * | 1998-04-09 | 1998-06-10 | Ciba Geigy Ag | Organic compounds |
| GB0020498D0 (en) * | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
| US6986938B2 (en) * | 2001-10-03 | 2006-01-17 | A & A Manufacturing Co., Inc. | Bellows with molded panels |
| AR037097A1 (es) * | 2001-10-05 | 2004-10-20 | Novartis Ag | Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento |
| PE20040167A1 (es) * | 2002-03-28 | 2004-05-26 | Novartis Ag | Amidas del acido sulfamico |
| PE20040693A1 (es) * | 2002-11-14 | 2004-11-23 | Novartis Ag | N-sulfonilaminotiazol como mediadores de la sulfatasa de esteroides |
-
2005
- 2005-03-17 GB GBGB0505541.3A patent/GB0505541D0/en not_active Ceased
-
2006
- 2006-03-15 WO PCT/EP2006/002382 patent/WO2006097292A1/en active Application Filing
- 2006-03-15 US US11/908,895 patent/US20090227620A1/en not_active Abandoned
- 2006-03-15 RU RU2007138263/15A patent/RU2007138263A/ru not_active Application Discontinuation
- 2006-03-15 CA CA002599470A patent/CA2599470A1/en not_active Abandoned
- 2006-03-15 KR KR1020077021073A patent/KR20070113226A/ko not_active Application Discontinuation
- 2006-03-15 BR BRPI0607795-1A patent/BRPI0607795A2/pt not_active IP Right Cessation
- 2006-03-15 MX MX2007011320A patent/MX2007011320A/es not_active Application Discontinuation
- 2006-03-15 EP EP06707567A patent/EP1861098A1/en not_active Withdrawn
- 2006-03-15 CN CNA2006800080245A patent/CN101137375A/zh active Pending
- 2006-03-15 JP JP2008501223A patent/JP2008533079A/ja active Pending
- 2006-03-15 AU AU2006224796A patent/AU2006224796A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008533079A5 (ja) | ||
| JP2023002662A5 (ja) | ||
| JP2021063088A5 (ja) | ||
| JP2018507914A5 (ja) | ||
| JP2007536311A5 (ja) | ||
| JP2018518537A5 (ja) | ||
| JP2008513510A5 (ja) | ||
| WO2007093183A3 (en) | Use of a compound that enhances gabaa-ergic neurotransmission for the treatment of inflammatory diseases | |
| NZ586751A (en) | Use of CDDO methyl ester (methyl 2-cyano-3,12-dioxoleana-1,9(11)-dien-28-oate) for the treatment of renal diseases and for improving kigney function | |
| JP2007504174A5 (ja) | ||
| BRPI0115910B8 (pt) | medicamento compreendendo 5-[(r)-2-(5,6-dietil-indan-2ilamino)-1-hidróxi-etil]-8-hidróxi-1h-quinolin-2-ona e corticóides para o tratamento de doencas inflamatórias ou obstrutivas das vias aéreas | |
| HK1126119A1 (en) | Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3- propanaediol derivative as active ingredient, and its use in manufacture of medicines for preventing or treating inflammatory bowel disease 2--13- | |
| EP2248519A3 (en) | Non-mucoadhesive film dosage forms | |
| JP2010518122A5 (ja) | ||
| JP2005506370A5 (ja) | ||
| JP2009502743A5 (ja) | ||
| WO2008022256A3 (en) | Methods and compositions for preventing or treating age-related diseases | |
| RU2007138263A (ru) | Противовоспалительные соединения | |
| JP2015524444A5 (ja) | ||
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| WO2007057221A3 (en) | Pharmaceutical compositions for the treatment of inflammatory and obstructive airways diseases | |
| JP2012508256A5 (ja) | ||
| JP2015510916A5 (ja) | ||
| PH12020551911A1 (en) | Use of riluzole oral disintigrating tablets for treating diseases | |
| EA202190544A1 (ru) | Применение распадающихся в полости рта таблеток рилузола для лечения заболеваний |